Wealth Enhancement Advisory Services, LLC Neurocrine Biosciences Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 19,107 shares of NBIX stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,107
Previous 5,806
229.09%
Holding current value
$2.55 Million
Previous $642,000
273.99%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
651Shares Held
97.3MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$739 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$649 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$357 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...